Atossa Therapeutics Inc. (ATOS) Fundamentals

Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
SHARE INFORMATION
Market Cap$ 146,883,968
Shares Outstanding126,624,110
Float126,565,081
Percent Float99.95%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.18
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions197
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months2,481,574
Institutional Holdings Percent58.5%
Institutional Sold Previous 3 Months5,856,143
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months250,000
Insider Holdings Percent0.4
Insider Sold Previous 3 Months-
Insider Shares Owned549,108
TRADING INFO
52 Week High$ 8.08
52 Week Low$ 0.84
52 Week High Change$ -83.93
21 Day Moving Average$ 1.0792
21 Day Extended Moving Average$ 1.0857
50 Day Moving Average$ 1.025
50 Day Extended Moving Average$ 1.0861
200 Day Moving Average$ 1.7385
200 Day Extended Moving Average$ 1.6623
10 Day Average Volume2,897,372
20 Day Average Volume2,287,182
30 Day Average Volume1,921,775
50 Day Average Volume1,898,794
Alpha0.017619
Beta1.9912
Standard Deviation0.450424
R20.043823
7 Day Price Change$ 0.09
7 Day Percent Change8.41%
21 Day Price Change$ -0.02
21 Day Percent Change-1.69%
30 Day Price Change$ 0.202
30 Day Percent Change21.09%
Month to Date Price Change$ 0.1877
Month to Date Percent Change19.3%
Quarter to Date Price Change$ -0.09
Quarter to Date Percent Change-7.2%
180 Day Price Change$ -0.44
180 Day Percent Change-27.5%
200 Day Price Change$ -0.85
200 Day Percent Change-42.29%
Year to Date Price Change$ -0.44
Year to Date Percent Change-27.5%

Atossa Therapeutics Inc. (ATOS) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.10
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio58.90
Leverage Ratio1.00
Quick Ratio56.90
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-6.40
Enterprise Value$ 5,577,989
Price to Sales0.00
Price to Free Cash-8.60
PE High Last 5 Years-0.50
Price To Book1.10
Price To Cash Flow0.00
PE Low Last 5 Years-0.40
Price to Tangible Book1.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-16.15
Return on Equity-16.37
Return on Capital-15.90

Atossa Therapeutics Inc. (ATOS) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBDO USA, LLP
CEOSteven C. Quay
Emplyoees6
Last AuditUE
CIK0001488039
IndustryBiotechnology
SectorHealthcare
NAICSIn-Vitro Diagnostic Substance Manufacturing(325413)
CONTACT INFO
Address107 Spring Street
Seattle, WA 98104
Websitehttps://www.atossatherapeutics.com
Facsimile+1 206 902-9658
Telephone+1 206 325-6068
Emailkyle.guse@atossainc.com
Your Recent History
NASDAQ
ATOS
Atossa The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220703 12:03:53